EUCTR2009-013485-23-DE进行中（未招募）不适用
A Multicentre, Double-blind, Placebo-Controlled, Parallel Group Study of the Effect of Oral Etamsylate (Dicynone®) in Patients with Menorrhagia
OM PHARMA0 个研究点目标入组 230 人开始时间: 2009年12月2日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 230
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Females aged = 18 to = 50, with excessive menstrual blood loss of = 80 to = 250 mL per menstruation and regular menstrual cycle.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •Patients with systemic pathology which can influence haemostasis, patients with complex hyperplasia with or w/o atypia, endometrial carcinoma, severe adenomyosis or with submucous fibroids, patients with uterine cavity > 10 weeks of pregnancy size, patients pregnant or lactating and unreliable patients.
研究者
相似试验
进行中（未招募）
不适用
A Multicentre, Double-blind, Placebo-Controlled, Parallel Group Study of the Effect of Oral Etamsylate (Dicynone®) in Patients with Menorrhagia - Effects of Oral Etamsylate in Patients with MenorrhagiaMenorrhagia in patients with regular menstrual cycleMedDRA version: 12.0Level: LLTClassification code 10027313Term: MenorrhagiaEUCTR2009-013485-23-PTOM PHARMA230
进行中（未招募）
1 期
A Multicentre, Double-blind, Placebo-Controlled, Parallel Group Study of the Effect of Oral Etamsylate (Dicynone®) in Patients with Menorrhagia - Effects of Oral Etamsylate in Patients with MenorrhagiaMenorrhagia in patients with regular menstrual cycleMedDRA version: 12.0Level: LLTClassification code 10027313Term: MenorrhagiaEUCTR2009-013485-23-FROM PHARMA230
进行中（未招募）
1 期
A study to assess the safety and tolerability of different doses of WVE-210201 in patients with Duchenne Muscular DystrophyMedDRA version: 20.0 Level: PT Classification code 10013801 Term: Duchenne muscular dystrophy System Organ Class: 10010331 - Congenital, familial and genetic disordersDuchenne Muscular DystrophyEUCTR2017-002686-21-GBWave Life Sciences Ltd.32
进行中（未招募）
1 期
A study to assess the safety and tolerability of different doses of WVE-210201 in patients with Duchenne Muscular DystrophyMedDRA version: 20.0 Level: PT Classification code 10013801 Term: Duchenne muscular dystrophy System Organ Class: 10010331 - Congenital, familial and genetic disordersDuchenne Muscular DystrophyEUCTR2017-002686-21-BEWave Life Sciences Ltd.32
进行中（未招募）
1 期
A study to assess the safety and tolerability of different doses of WVE-210201 in patients with Duchenne Muscular DystrophyDuchenne Muscular DystrophyEUCTR2017-002686-21-FRWave Life Sciences Ltd.32